| Patent | Date |
|---|
Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use
Grant 11,454,633 - Ruike , et al. September 27, 2 | 2022-09-27 |
Anti-myostatin Antibodies And Methods Of Use
App 20220275076 - RUIKE; Yoshinao ; et al. | 2022-09-01 |
Antigen-binding Molecule Containing Modified Fc Region
App 20220242934 - Igawa; Tomoyuki ; et al. | 2022-08-04 |
Anti-myostatin antibodies and methods of use
Grant 11,359,009 - Ruike , et al. June 14, 2 | 2022-06-14 |
Antibody Constant Region Variant
App 20220064264 - Igawa; Tomoyuki ; et al. | 2022-03-03 |
Method of modifying isoelectric point of antibody via amino acid substitution in CDR
Grant 11,248,053 - Igawa , et al. February 15, 2 | 2022-02-15 |
Cytotoxicity-inducing Therapeutic Agent
App 20220041756 - Nezu; Junichi ; et al. | 2022-02-10 |
Antigen-binding molecule containing modified Fc region
Grant 11,142,563 - Igawa , et al. October 12, 2 | 2021-10-12 |
Polypeptide Comprising Aggrecan Binding Domain And Carrying Moiety
App 20210221875 - KITAMURA; Hidetomo ; et al. | 2021-07-22 |
Cytotoxicity-inducing therapeutic agent
Grant 11,066,483 - Nezu , et al. July 20, 2 | 2021-07-20 |
Anti-c1s Antibodies And Methods Of Use
App 20210032365 - FENG; Shu ; et al. | 2021-02-04 |
Anti-myostatin Antibodies, Polypeptides Containing Variant Fc Regions, And Methods Of Use
App 20200317768 - RUIKE; Yoshinao ; et al. | 2020-10-08 |
Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use
Grant 10,738,111 - Ruike , et al. A | 2020-08-11 |
Method For Altering Plasma Retention And Immunogenicity Of Antigen-binding Molecule
App 20200199241 - Igawa; Tomoyuki ; et al. | 2020-06-25 |
MODIFIED Fc REGION OF ANTIBODY
App 20200181257 - Kuramochi; Taichi ; et al. | 2020-06-11 |
Method for altering plasma retention and immunogenicity of antigen-binding molecule
Grant 10,618,965 - Igawa , et al. | 2020-04-14 |
Antigen-binding Molecule Having Regulated Conjugation Between Heavy-chain And Light-chain
App 20200087380 - Kuramochi; Taichi ; et al. | 2020-03-19 |
Anti-nr10 Antibody And Use Thereof
App 20200002429 - Kuramochi; Taichi ; et al. | 2020-01-02 |
Antibody constant region variants with reduced Fcgammar binding
Grant 10,435,458 - Kuramochi , et al. O | 2019-10-08 |
THERAPEUTIC ANTIGEN-BINDING MOLECULE WITH A FcRn-BINDING DOMAIN THAT PROMOTES ANTIGEN CLEARANCE
App 20190233525 - Igawa; Tomoyuki ; et al. | 2019-08-01 |
Antibody Constant Region Variant
App 20190211081 - Igawa; Tomoyuki ; et al. | 2019-07-11 |
Therapeutic antigen-binding molecule with a FcRn-binding domain that promotes antigen clearance
Grant 10,253,100 - Igawa , et al. | 2019-04-09 |
Antibody constant region variant
Grant 10,253,091 - Igawa , et al. | 2019-04-09 |
Anti-myostatin Antibodies And Methods Of Use
App 20190002548 - RUIKE; Yoshinao ; et al. | 2019-01-03 |
Modified antibody constant regions
Grant 10,150,808 - Kuramochi , et al. Dec | 2018-12-11 |
Anti-myostatin Antibodies, Polypeptides Containing Variant Fc Regions, And Methods Of Use
App 20180319876 - RUIKE; Yoshinao ; et al. | 2018-11-08 |
Anti-myostatin Antibodies, Polypeptides Containing Variant Fc Regions, And Methods Of Use
App 20180319877 - RUIKE; Yoshinao ; et al. | 2018-11-08 |
Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use
Grant 10,000,560 - Ruike , et al. June 19, 2 | 2018-06-19 |
Heterodimerized Polypeptide
App 20180155451 - Mimoto; Futa ; et al. | 2018-06-07 |
Method Of Modifying Isoelectric Point Of Antibody Via Amino Acid Substitution In Cdr
App 20180142027 - Igawa; Tomoyuki ; et al. | 2018-05-24 |
Heterodimerized polypeptide
Grant 9,890,218 - Mimoto , et al. February 13, 2 | 2018-02-13 |
Method of modifying isoelectric point of antibody via amino acid substitution in CDR
Grant 9,828,429 - Igawa , et al. November 28, 2 | 2017-11-28 |
Humanized Anti-Epiregulin Antibody, and Cancer Therapeutic Agent Comprising Said Antibody as Active Ingredient
App 20170129950 - SHIRAIWA; Hirotake ; et al. | 2017-05-11 |
Humanized anti-epiregulin antibody, and cancer therapeutic agent comprising said antibody as active ingredient
Grant 9,556,264 - Shiraiwa , et al. January 31, 2 | 2017-01-31 |
Nucleic acids encoding anti-NR10 antibodies
Grant 9,399,680 - Kuramochi , et al. July 26, 2 | 2016-07-26 |
Anti-Myostatin Antibodies, Polypeptides Containing Variant Fc Regions, and Methods of Use
App 20160200807 - RUIKE; Yoshinao ; et al. | 2016-07-14 |
Anti-AXL antibody
Grant 9,340,615 - Maeda , et al. May 17, 2 | 2016-05-17 |
Anti-Glypican-3 Antibody Having Improved Kinetics in Plasma
App 20150315278 - IGAWA; Tomoyuki ; et al. | 2015-11-05 |
Method of Modifying Isoelectric Point of Antibody Via Amino Acid Substitution in CDR
App 20150284465 - Igawa; Tomoyuki ; et al. | 2015-10-08 |
Antibody Constant Region Variant
App 20150274809 - Igawa; Tomoyuki ; et al. | 2015-10-01 |
Method of modifying isoelectric point of antibody via amino acid substitution in CDR
Grant 9,096,651 - Igawa , et al. August 4, 2 | 2015-08-04 |
MODIFIED Fc REGION OF ANTIBODY
App 20150210763 - Kuramochi; Taichi ; et al. | 2015-07-30 |
Anti-nr10 Antibody And Use Thereof
App 20150175704 - Kuramochi; Taichi ; et al. | 2015-06-25 |
Antigen-binding Molecule Containing Modified Fc Region
App 20150166636 - Igawa; Tomoyuki ; et al. | 2015-06-18 |
Humanized Anti-Epiregulin Antibody, and Cancer Therapeutic Agent Comprising Said Antibody as Active Ingredient
App 20150110793 - Shiraiwa; Hirotake ; et al. | 2015-04-23 |
Antigen-binding Molecule Having Regulated Conjugation Between Heavy-chain And Light-chain
App 20140370020 - Kuramochi; Taichi ; et al. | 2014-12-18 |
THERAPEUTIC ANTIGEN-BINDING MOLECULE WITH A FcRn-BINDING DOMAIN THAT PROMOTES ANTIGEN CLEARANCE
App 20140363428 - Igawa; Tomoyuki ; et al. | 2014-12-11 |
Heterodimerized Polypeptide
App 20140199294 - Mimoto; Futa ; et al. | 2014-07-17 |
Cytotoxicity-inducing Therapeutic Agent
App 20140112914 - Nezu; Junichi ; et al. | 2014-04-24 |
Method For Altering Plasma Retention And Immunogenicity Of Antigen-binding Molecule
App 20140105889 - Igawa; Tomoyuki ; et al. | 2014-04-17 |
Fc-gamma-RIIb-SPECIFIC Fc ANTIBODY
App 20140093496 - Mimoto; Futa ; et al. | 2014-04-03 |
Anti-nr10 Antibody And Use Thereof
App 20140039165 - Kuramochi; Taichi ; et al. | 2014-02-06 |
Anti-glypican-3 Antibody Having Improved Kinetics In Plasma
App 20130295612 - IGAWA; Tomoyuki ; et al. | 2013-11-07 |
Anti-NR10 antibody and use thereof
Grant 8,575,317 - Kuramochi , et al. November 5, 2 | 2013-11-05 |
Anti-glypican-3 antibody having improved kinetics in plasma
Grant 8,497,355 - Igawa , et al. July 30, 2 | 2013-07-30 |
Antibody Constant Region Variant
App 20130101581 - Kuramochi; Taichi ; et al. | 2013-04-25 |
Modified Antibody Constant Regions
App 20120238729 - Kuramochi; Taichi ; et al. | 2012-09-20 |
Anti-axl Antibody
App 20120121587 - Maeda; Atsuhiko ; et al. | 2012-05-17 |
Antibody Constant Region Variant
App 20120071634 - Igawa; Tomoyuki ; et al. | 2012-03-22 |
Anti-nr10 Antibody And Use Thereof
App 20110229459 - Kuramochi; Taichi ; et al. | 2011-09-22 |
Anti-nr10 Antibody And Use Thereof
App 20110129459 - Kuramochi; Taichi ; et al. | 2011-06-02 |
Method of Modifying Isoelectric Point of Antibody Via Amino Acid Substitution in CDR
App 20110076275 - Igawa; Tomoyuki ; et al. | 2011-03-31 |
Anti-glypican-3 Antibody Having Improved Kinetics In Plasma
App 20100239577 - Igawa; Tomoyuki ; et al. | 2010-09-23 |
| 